1. CTNI-27. FIRST-IN-PEDIATRICS PHASE I STUDY OF GDC-0084 (PAXALISIB), A CNS-PENETRANT PI3K/mTOR INHIBITOR, IN NEWLY DIAGNOSED DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG) OR OTHER DIFFUSE MIDLINE GLIOMA (DMG). (9th November 2020) Authors: Tinkle, Christopher; Huang, Jie; Campagne, Olivia; Pan, Haitao; Onar-Thomas, Arzu; Chiang, Jason; Klimo, Paul; Boop, Rick; Patay, Zoltan; Shulkin, Barry; Lucas, John; Merchant, Thomas; Upadhyaya, Santhosh; Robinson, Giles; Vinitsky, Anna; Stewart, Clinton; Gajjar, Amar Journal: Neuro-oncology Issue: Volume 22(2020)Supplement 2 Page Start: ii48 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗